AI assistant
BIO-TECHNE Corp — Director's Dealing 2023
Jul 5, 2023
30718_dirs_2023-07-05_32f4e326-3cb8-4989-be79-85cfb6285da7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-06-30
Reporting Person: Kummeth Charles R. (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-06-30 | Common Stock | M | 616676 | $26.65 | Acquired | 1729493 | Direct |
| 2023-06-30 | Common Stock | F | 390727 | $81.63 | Disposed | 1338766 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | Stock Options (Right to Buy) | $26.65 | M | 616676 | Disposed | 2023-08-18 | Common Stock (616676) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 400 | Indirect |
| Common Stock | 400 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $31.2625 | 2024-08-09 | Common Stock (779084) | 779084 | Direct |
| Stock Options (Right to Buy) | $44.33 | 2025-08-08 | Common Stock (361336) | 361336 | Direct |
| Stock Options (Right to Buy) | $44.33 | 2025-08-08 | Common Stock (240888) | 240888 | Direct |
| Stock Options (Right to Buy) | $47.6025 | 2026-08-07 | Common Stock (342900) | 342900 | Direct |
| Restricted Stock Units | $ | Common Stock (52900) | 52900 | Direct | |
| Stock Options (Right to Buy) | $47.6025 | 2026-08-07 | Common Stock (228600) | 228600 | Direct |
| Restricted Stock Units | $ | Common Stock (51516) | 51516 | Direct | |
| Stock Options (Right to Buy) | $66.9675 | 2027-08-05 | Common Stock (299768) | 299768 | Direct |
| Stock Options (Right to Buy) | $66.9675 | 2027-08-05 | Common Stock (153180) | 153180 | Direct |
| Stock Options (Right to Buy) | $66.9675 | 2027-08-05 | Common Stock (66600) | 66600 | Direct |
| Stock Options (Right to Buy) | $66.9675 | 2027-08-05 | Common Stock (66600) | 66600 | Direct |
| Restricted Stock Units | $ | Common Stock (32064) | 32064 | Direct | |
| Stock Options (Right to Buy) | $120.455 | 2028-08-06 | Common Stock (125260) | 125260 | Direct |
| Stock Options (Right to Buy) | $120.455 | 2028-08-06 | Common Stock (83504) | 83504 | Direct |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (1200000) | 1200000 | Direct |
Footnotes
F1: Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024.
F2: Fully exercisable.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F4: 17,632 shares vest on each of 8/15/2023 and 8/15/2025, and 17,636 shares vest on 8/15/2024.
F5: Options to purchase 57,152 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 57,148 shares vest on each of 8/7/2022 and 8/7/2023.
F6: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: Options to purchase 38,292 shares vest on 8/5/21 and options to purchase 38,296 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
F8: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F9: Options to purchase 22,200 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.
F10: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F11: Options to purchase 20,876 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
F12: 600,000 options vest in full or in part on 7/1/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator), and 600,000 options vest in full or in part on 7/1/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).